Efficacy and Safety of COVID-۱۹ Vaccines in Different Variants and Doses: A Systematic Review

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 129

This Paper With 12 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_INJER-9-4_008

تاریخ نمایه سازی: 25 دی 1401

Abstract:

Background and aims: Today, with the outbreak of the coronavirus disease ۱۹ (COVID-۱۹) pandemic, we have witnessed many efforts by different countries to produce a vaccine for this disease. Each vaccine has been marketed with different efficiencies, thus this research was designed to determine the efficacy of different types of these vaccines in ۲۰۲۲. Methods: The present research was a systematic review. Researchers surveyed six international databases, including Medline/PubMed, ProQuest, Scopus, EMBASE, Google Scholar, and the ISI Web of Science, in January ۲۰۲۲. After reviewing the titles and abstracts of articles, ۶۰ articles entered the final stage, and their full texts were reviewed based on the study purpose. All the vaccines included in the study were approved by the World Health Organization (WHO) or the Ministry of Health of the manufacturer country in the third phase of the clinical trial. Results: All current vaccination platforms provide adequate protection against severe acute respiratory syndrome coronavirus ۲ (SARC-CoV-۲) infection and significantly reduce the risk of serious infection. In addition, people who receive two vaccine doses have higher efficacy than those who only receive one dose of each vaccine. The results of the studies demonstrated that the effectiveness of vaccines is different in various groups and countries. According to the results of the reviewed studies, the Pfizer vaccine had an overall effect of ۱۰۰% on the age group of ۱۲-۱۵ years. The overall effect of the Moderna vaccine varied from ۷۸.۶% to ۹۷% in different groups. In general, the available vaccines for COVID-۱۹ are less effective in the Omicron variant. On the other hand, it seems that the COVID-۱۹ vaccines had better efficacy on the alpha variant. Conclusion: Overall, the vaccines used in the COVID-۱۹ pandemic have acceptable efficacy. Although serious side effects caused by the injection of the vaccine have been rarely reported in some studies, it seems that the safety of these vaccines is acceptable in general.

Authors

Hamed Delam

Student Research Committee, Larestan University of Medical Sciences, Larestan, Iran

Sara Moghaddam

Department of Nursing, School of Nursing, Larestan University of Medical Sciences, Larestan, Iran / Department of Nursing, School of Nursing and Midwifery, Jahrom University of Medical Sciences, Jahrom, Iran

Reza Zare

Student Research Committee, Larestan University of Medical Sciences, Larestan, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :